What causes a patient with end-stage renal disease (ESRD) or acute kidney injury (AKI) to worsen after undergoing hemodialysis (HD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Causes Patient Worsening After Hemodialysis

The most common cause of patient worsening after hemodialysis is intradialytic hypotension resulting from excessive ultrafiltration that depletes intravascular volume faster than compensatory mechanisms can respond, leading to end-organ hypoperfusion and associated complications. 1, 2

Primary Mechanisms of Post-Dialysis Deterioration

Intradialytic Hypotension and Hemodynamic Instability

  • Excessive ultrafiltration is the leading precipitant, occurring when fluid removal exceeds the rate of vascular refilling from interstitial compartments, causing rapid intravascular volume depletion 1, 2
  • Intradialytic hypotension (defined as systolic BP drop ≥20 mmHg or mean arterial pressure drop ≥10 mmHg) occurs in approximately 8% of all HD sessions and requires countermeasures like saline infusion or ultrafiltration reduction 3, 2
  • Inadequate peripheral vascular resistance response fails to compensate for acute volume loss—when the normal compensatory increase in PVR does not occur, blood pressure cannot be maintained despite preserved cardiac output 4
  • Episodes of intravascular volume depletion during HD contribute to more rapid loss of residual kidney function, creating a vicious cycle of worsening renal capacity 1

Cardiovascular Complications

  • Myocardial stunning results from repetitive hypotensive episodes, causing transient left ventricular dysfunction that accumulates over time with repeated dialysis sessions 3
  • Cardiac arrhythmias are triggered by rapid electrolyte shifts and volume depletion during aggressive ultrafiltration 3
  • Patients with pre-existing left ventricular hypertrophy or cardiac dysfunction are particularly vulnerable to hemodynamic instability during fluid removal 5

Paradoxical Hypertension During or After Dialysis

  • Excessive volume depletion can paradoxically trigger hypertension rather than hypotension through overstimulation of the renin-angiotensin system and sympathetic nervous system 1, 6
  • Accelerated ultrafiltration may worsen hypertension by causing hypotension that requires saline administration, ultimately worsening volume overload 6, 7
  • Removal of certain antihypertensive drugs during dialysis (enalapril, ramipril, atenolol, acebutolol, nadolol, minoxidil, nitroprusside) can precipitate rebound hypertension 1

Secondary Mechanisms

Electrolyte and Acid-Base Disturbances

  • Rapid shifts in potassium, calcium, and bicarbonate during dialysis can cause cardiac instability and arrhythmias 1
  • Dialysate calcium concentration that is too low (<1.25 mmol/L) can contribute to intradialytic hypotension and hemodynamic instability 1, 5

Residual Kidney Function Loss

  • Episodes of hypotension during HD accelerate the loss of residual kidney function through repetitive ischemic injury to remaining nephrons 1
  • Loss of residual kidney function increases dependence on ultrafiltration, creating greater hemodynamic stress with each subsequent dialysis session 1

Inadequate Dialysis Delivery

  • Hypotensive episodes force premature termination or reduction of dialysis time, resulting in inadequate solute clearance and uremic symptom persistence 1
  • Patients may experience prolonged recovery time (>6 hours in 27% of patients), feeling "washed out or drained" after treatment 3

Critical Risk Factors

Patient-Related Factors

  • Advanced age and multiple comorbidities reduce cardiovascular reserve and ability to compensate for volume shifts 2
  • Pre-existing cardiac dysfunction (congestive heart failure, ischemic heart disease, left ventricular hypertrophy) dramatically increases vulnerability to hemodynamic instability 5
  • Malnutrition and low albumin levels worsen prognosis and reduce oncotic pressure for vascular refilling 5

Dialysis Prescription Factors

  • Incorrect dry weight assessment is a major contributor—setting target weight too low causes excessive ultrafiltration and hypotension 8, 2
  • Large interdialytic weight gains necessitate aggressive ultrafiltration that exceeds compensatory capacity 8, 2
  • Inadequate dialysis time (standard 4 hours three times weekly) may be too short for safe fluid removal in volume-overloaded patients 6, 7

Prevention Strategies

Optimizing Ultrafiltration

  • Avoid excessive ultrafiltration by accurately assessing dry weight through careful clinical examination for volume overload signs 1, 8
  • Extend dialysis time beyond standard 4 hours when necessary to allow slower, better-tolerated fluid removal 6, 7
  • Minimize interdialytic weight gain through sodium restriction (<2g/day) and fluid restriction between sessions 8

Dialysis Prescription Modifications

  • Reduce dialysate temperature to improve hemodynamic stability during ultrafiltration 1
  • Increase dialysate sodium concentration to support blood pressure during fluid removal 1
  • Use dialysate calcium concentration of 1.25-1.5 mmol/L to prevent hypotension while avoiding excessive calcium loading 1, 5
  • Consider predialysis administration of midodrine (alpha-agonist) for patients with recurrent intradialytic hypotension 1

Preserving Residual Kidney Function

  • Maintain target hematocrit to optimize oxygen-carrying capacity and cardiovascular stability 1
  • Use loop diuretics in patients with residual kidney function to reduce ultrafiltration requirements 1, 8
  • Consider ACE inhibitors or ARBs for blood pressure control and renoprotection, though monitor for excessive GFR reduction 1, 8

Common Pitfalls to Avoid

  • Do not aggressively pursue dry weight reduction without considering the patient's cardiovascular reserve and ability to tolerate volume removal 8, 7
  • Avoid rapid blood pressure reduction that precipitates intradialytic hypotension requiring saline infusion, which worsens the underlying volume problem 6, 7
  • Do not ignore the "lag phenomenon"—blood pressure may continue decreasing for 8 months after achieving euvolemia, requiring ongoing dry weight reassessment 7
  • Recognize that conventional 4-hour dialysis three times weekly may be inadequate for safe ultrafiltration in many patients, particularly those with large interdialytic weight gains 6

Special Considerations for Acute Coronary Syndromes

  • Timing of dialysis in the first 48 hours after acute coronary syndrome requires individualized assessment of volume status, electrolyte disturbances, and bleeding potential 1
  • Dialysis prescriptions should be adjusted to maximize benefits while reducing hypotension risk during this vulnerable period 1
  • Collaboration between nephrology and cardiology teams is essential for balancing the need for volume removal against cardiovascular instability 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prevention of Intradialytic Hypotension in Hemodialysis Patients: Current Challenges and Future Prospects.

International journal of nephrology and renovascular disease, 2023

Research

Intensive Hemodialysis and Treatment Complications and Tolerability.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016

Research

Hemodynamic and volume changes during hemodialysis.

Hemodialysis international. International Symposium on Home Hemodialysis, 2003

Guideline

CKD-Related Hypertension Mechanisms and Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cilinidipine Use in CKD Stage 5 Hemodialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Dyspnea on Exertion After Water Intake in Hemodialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What do the AEIOUs (Access, Electrolytes, Infection control, Overload management, Uremic symptoms management) of hemodialysis stand for?
What is the most likely ECG finding in an adult patient with type 2 diabetes mellitus (T2DM), hypertension (HTN), and end-stage renal disease (ESRD) on hemodialysis, presenting with symptoms of fluid overload, including shortness of breath and significant bilateral lower limb swelling?
How is fluid balance managed in patients with dialysis?
What is the use of Bumetanide (a loop diuretic) in patients with Impaired renal function undergoing Hemodialysis (HD)?
What are the acute complications of hemodialysis and how are they managed?
What is the recommended treatment plan for a patient with a low-grade tear in the subscapularis and posterior two thirds of the supraspinatus tendon, moderate subacromial-subdeltoid bursitis, and an incidental finding of a probable intramuscular lipoma versus post-traumatic fatty infiltration in the infraspinatus muscle, one month post-injury?
Is it appropriate to use 5% dextrose (five percent dextrose) as the primary solution for potassium correction in a patient with hypokalemia and hypernatremia?
What is the optimal blood pressure target for a patient with a history of stroke and abdominal aortic aneurysm (AAA)?
When should antibiotics be changed in a patient with no significant improvement?
What is the initial treatment for a pediatric patient with supraventricular tachycardia (SVT)?
What is the pathophysiology of cellulitis in a general adult population?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.